COMMUNIQUÉS West-GlobeNewswire

Sol-Gel Reports First Quarter 2026 Financial Results and Provides Corporate Updates
28/05/2026
Sol-Gel received a Notice of Allowance for a method-of-use patent extending intellectual property protection for topical patidegib (SGT-610) until 2044 Sol-Gel completed an oversubscribed underwritten offering, raising [...]
CRISPR Therapeutics to Participate in Upcoming Investor Conferences
28/05/2026
ZUG, Switzerland and BOSTON, May 28, 2026 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP) today announced that members of its senior management team are scheduled to participate in the following investor [...]
Medicus Pharma Announces $22 Million Non-Dilutive Financing
28/05/2026
Financing Provides Immediate Growth Capital to Support Clinical Development Initiatives and Extends Projected Operating Cash Runway for Over Two (2) Years PHILADELPHIA, May 28, 2026 (GLOBE NEWSWIRE) -- Medicus Pharma [...]
SciSparc: Subsidiary NeuroThera Labs Received Conditional Regulatory Approval for Acquisition of CliniQuantum
28/05/2026
TEL AVIV, Israel, May 28, 2026 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) (“Company” or “SciSparc”), today announced that NeuroThera Labs Inc. (TSXV: NTLX) ("NeuroThera"), a clinical-stage pharmaceutical company [...]
MediPharm Labs Reminds Shareholders of Upcoming Annual and Special Meeting
28/05/2026
Annual and Special Meeting to be held virtually on Wednesday, June 17, 2026 at 11:00 a.m. (Eastern Time). The Board of Directors recommends shareholders vote FOR all director nominees and resolutions, before the 11:00 a [...]
World Trade Center Health Program Launches National Awareness Initiative to Reach Those Who Were Impacted by 9/11 as Children or Teens
28/05/2026
New outreach initiative features New York City sketch artist and influencer Devon Rodriguez to reach individuals impacted by 9/11 at an early age and help them understand they may be eligible for no-cost medical [...]
Thousands of people march to protest Ford’s hospital privatization, Demand he return that funding to our public hospitals
28/05/2026
TORONTO, May 28, 2026 (GLOBE NEWSWIRE) -- They are coming from towns across the province, where their local hospitals have been pushed into deficit and forced by the Ford government to make cuts. They are coming in the [...]
Metagenomi Therapeutics, Inc. to Present at the Jefferies Global Healthcare Conference
28/05/2026
EMERYVILLE, Calif., May 28, 2026 (GLOBE NEWSWIRE) -- Metagenomi Therapeutics, Inc. (Nasdaq: MGX) (the “Company”), an in vivo genome editing company capitalizing on its proprietary technologies to create curative genetic [...]
BioCardia Announces Japan PMDA Record Of Advice Supports Regulatory Submission For Approval Of CardiAMP Cell Therapy For Ischemic Heart Failure
28/05/2026
Submission Anticipated in Q4 2026 SUNNYVALE, Calif., May 28, 2026 (GLOBE NEWSWIRE) -- BioCardia ® , Inc. [Nasdaq: BCDA], a global leader in cellular and cell-derived therapeutics for the treatment of cardiovascular and [...]
Akebia Therapeutics to Present at the 2026 Jefferies Global Healthcare Conference
28/05/2026
CAMBRIDGE, Mass., May 28, 2026 (GLOBE NEWSWIRE) -- Akebia Therapeutics®, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced that [...]
Conavi Medical Reports Fiscal Second Quarter 2026 Results and Operational Highlights
28/05/2026
- Achieves U.S. FDA 510(k) Clearance for Next-Generation Hybrid IVUS-OCT Imaging System - Wins Multiple Industry Awards Recognizing Innovation and Leadership in Intravascular Imaging - Advances U.S. Commercial Readiness [...]
Artiva Biotherapeutics to Participate in the 2026 Jefferies Global Healthcare Conference
28/05/2026
SAN DIEGO, May 28, 2026 (GLOBE NEWSWIRE) -- Artiva Biotherapeutics, Inc. (Nasdaq: ARTV), a clinical-stage biotechnology company whose mission is to develop effective, safe and accessible cell therapies for patients with [...]
Aclaris Therapeutics to Participate in the 2026 Jefferies Global Healthcare Conference
28/05/2026
WAYNE, Pa., May 28, 2026 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing novel product candidates for immuno-inflammatory diseases, today [...]
Actinogen receives positive EMA scientific advice aligned with prior FDA guidance for its Alzheimer’s disease program
28/05/2026
XanaMIA randomized, pivotal trial of oral Xanamem 10 mg fully enrolled and remains on track for topline final results in November 2026 SYDNEY, May 28, 2026 (GLOBE NEWSWIRE) -- Actinogen Medical Limited (ASX: ACW) today [...]
ViCentra Scales Commercial Manufacturing, Triples Capacity and Strengthens Unit Economics
28/05/2026
Commercial-scale production of Kaleido consumables begins at contract manufacturer Phillips Medisize Manufacturing capacity more than triples, with initial capacity to support over 17,000 users Volume manufacturing [...]
Anaveon Reports Clinical Benefit of ANV600 in the EXPAND-1 Phase 1 Clinical Trial at ASCO 2026 and Actively Seeks Partners for its Legacy Oncology Portfolio
28/05/2026
BASEL, Switzerland, May 28, 2026 (GLOBE NEWSWIRE) -- Anaveon, a late-stage preclinical biotechnology company focused on reprogramming the immune system for the treatment of autoimmune and inflammatory diseases, today [...]
Groundbreaking therapy for advanced heart failure: Outcomes of the BIOVAT-HF clinical trial published in NEJM
28/05/2026
Repairon Announces Publication of Clinical Trial Results for Engineered Human Heart Muscle Tissue in the New England Journal of Medicine GÖTTINGEN, Germany and PROVIDENCE, R.I., May 28, 2026 (GLOBE NEWSWIRE) -- Repairon [...]
XL‑protein Launches Spin-Off PASylANTA Therapeutics to Develop Long‑Acting IL‑1Ra Biobetters
28/05/2026
Freising, Germany, May 28, 2026 (GLOBE NEWSWIRE) -- XL‑protein GmbH today announced the launch of PASylANTA Therapeutics GmbH , a new Germany-based biotechnology company focused on the development of long‑acting IL‑1 [...]
InnoCare Announces the Acceptance of New Drug Application for Orelabrutinib in Primary Immune Thrombocytopenia in China
28/05/2026
BEIJING, May 28, 2026 (GLOBE NEWSWIRE) -- InnoCare Pharma (HKEX: 9969; SSE: 688428), a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, announced today that the Center for [...]

Pages